Torrent Pharmaceuticals Ltd (NSE:TORNTPHARM)
₹ 2612.55 -80.35 (-2.98%) Market Cap: 884.21 Bil Enterprise Value: 912.62 Bil PE Ratio: 59.16 PB Ratio: 13.18 GF Score: 96/100

Q1 2024 Torrent Pharmaceuticals Ltd Earnings Call Transcript

Aug 07, 2023 / 12:30PM GMT
Release Date Price: ₹2051.4 (-0.52%)
Operator

Ladies and gentlemen, good day, and welcome to the Q1 FY '24 Earnings Conference Call of Torrent Pharmaceuticals. (Operator Instructions) Please note that this conference is being recorded. I would now like to hand the conference over to Mr. Sudhir Menon, Chief Financial Officer and Executive Director. Thank you, and over to you, sir.

Sudhir Menon
Torrent Pharmaceuticals Limited - Executive Director of Finance & CFO

Thank you. Good evening, and welcome to Quarter 1 FY '24 Earnings Call of Torrent. While we see -- while we continue to see strong underlying market beating growth in our branded business. On the generic side, Germany has registered a sequential increase in the revenues on the back of tender wins in the last 3 quarters, while the U.S. business has delivered stable revenues for the quarter.

In terms of key financial performance indicators for quarter 1, revenues were INR 2,591 crores, up by 10% compared to the previous year same quarter. Operating EBITDA for the quarter is INR 791 crores. Operating EBITDA margin stands at 30.5% and

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot